Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies

Kuros Biosciences

Market Cap: CHF 914.8m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

Gerresheimer

Market Cap: CHF 945.0m

Provides drug containment solutions in Germany and internationally.

Viatris

Market Cap: CHF 18.7b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Evotec

Market Cap: CHF 658.7m

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Joincare Pharmaceutical Group IndustryLtd

Market Cap: US$18.5b

Joincare Pharmaceutical Group Industry Co.,Ltd.

Bristol-Myers Squibb

Market Cap: CHF 132.4b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Basilea Pharmaceutica

Market Cap: CHF 644.6m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

AstraZeneca

Market Cap: CHF 183.7b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Santhera Pharmaceuticals Holding

Market Cap: CHF 246.1m

A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.

Jazz Pharmaceuticals

Market Cap: CHF 16.7b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

BioMarin Pharmaceutical

Market Cap: CHF 13.5b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Novartis

Market Cap: CHF 239.2b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Roche Holding

Market Cap: CHF 294.5b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Tecan Group

Market Cap: CHF 2.2b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Qiagen

Market Cap: CHF 9.2b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Illumina

Market Cap: CHF 20.6b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Orion Oyj

Market Cap: CHF 11.2b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Gilead Sciences

Market Cap: CHF 165.0b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Sanofi

Market Cap: CHF 90.3b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

MindMaze Therapeutics Holding

Market Cap: CHF 35.6m

Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.

Roche Holding

Market Cap: CHF 294.5b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

MannKind

Market Cap: CHF 1.3b

A biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care.

Bayer

Market Cap: CHF 48.1b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

Novavax

Market Cap: CHF 1.3b

A biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally.

Formycon

Market Cap: CHF 338.6m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

Eli Lilly

Market Cap: CHF 1.1t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Idorsia

Market Cap: CHF 1.7b

A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.

Grifols

Market Cap: CHF 6.1b

Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.

Newron Pharmaceuticals

Market Cap: CHF 244.7m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Novartis

Market Cap: CHF 239.2b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Merck KGaA

Market Cap: CHF 60.7b

Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.

CRISPR Therapeutics

Market Cap: CHF 5.2b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Celldex Therapeutics

Market Cap: CHF 3.4b

A biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.

Bachem Holding

Market Cap: CHF 5.6b

Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.

Siegfried Holding

Market Cap: CHF 3.9b

Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.

Johnson & Johnson

Market Cap: CHF 630.9b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.